Effect of β1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril

European Journal of Heart Failure

Volumn 2, Issue 4, 2000, Pages 407-412

  Sturm, B ^a   Pacher, R ^a   Strametz Juranek, J ^a   Berger, R ^a   Frey, B ^a   Stanek, B ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blockade; Advanced left ventricular dysfunction; Heart failure; High dose enalapril; Progression of disease

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; IMPOTENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SURVIVAL; TACHYCARDIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATENOLOL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION;

EID: 0034534141     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00120-3     Document Type: Article

References (25)

1. Consensus recommendations for the management of chronic heart failure
2. Major β blocker mortality trials in chronic heart failure: A critical review
3. Effects of two different enalapril dosages on clinical, hemodynamic and neurohumoral response of patients with severe congestive heart failure
4. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure
5. Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
6. ACE inhibitor dosage at the time of listing predicts survival
7. Effects on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
8. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
9. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor lisinopril on morbidity and mortality in chronic heart failure
10. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure
11. Effects of intravenous milrinone followed by titration of high dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure
12. Combined oral positive inotropic and β-blocker therapy for treatment of refractory class IV heart failure
13. Safety efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation
14. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
15. Effects of atenolol on 24-hour heart rate variability and left ventricular function in heart failure patients treated with high-dose angiotensin-converting enzyme inhibitors
16. Effects of atenolol as add-on therapy to fosinopril in heart failure
17. Atenolol in dilated cardiomyopathy: A clinical instrumental study
18. Medium-term effects of beta-blockade on left ventricular mechanics: A double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction
19. Long-term β-blocker therapy improves autonomous nervous regulation in advanced congestive heart failure: A longitudinal heart rate variability study
20. The Cardiac Insufficiency Bisoprolol Study (CIBIS II): A randomized trial
21. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Results of the Metoprolol in Dilated Cardiomyopathy (MDC) Trial. A randomized, double-blind, placebo controlled multi-centre study
22. 3-Year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial
23. Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
24. Beta-blockers in heart failure
25. Time course of improvement in left ventricular function mass and geometry in patients with congestive heart failure treated with β-adrenergic blockade